ID
43233
Descripción
Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia; ODM derived from: http://clinicaltrials.gov/show/NCT02034227
Link
http://clinicaltrials.gov/show/NCT02034227
Palabras clave
Versiones (3)
- 3/8/15 3/8/15 - Julian Varghese
- 3/8/15 3/8/15 - Julian Varghese
- 20/9/21 20/9/21 -
Subido en
20 de septiembre de 2021
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Acute Myeloid Leukemia NCT02034227
Eligibility Acute Myeloid Leukemia NCT02034227
- StudyEvent: Eligibility Acute Myeloid Leukemia NCT02034227
Descripción
Exclusion Criteria
Descripción
are eligible for any standard therapy known to be life prolonging or life saving
Tipo de datos
boolean
Descripción
have diagnosis of aml french-american-british (fab) classification (fab) m3 (acute promyelocytic leukemia (apl))
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0457329
Descripción
are receiving concurrent chemotherapy, radiotherapy, immunotherapy, biological or hormonal treatment for cancer.
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C3665472
- UMLS CUI [2]
- C1522449
- UMLS CUI [3]
- C0021083
- UMLS CUI [4]
- C1531518
- UMLS CUI [5]
- C0279025
Descripción
have undergone anticancer therapy including chemotherapy (except for hydroxycarbamide at a maximum daily dose of 3000 mg), endocrine therapy, immunotherapy, or the use of other investigational agents within 4 weeks before study entry.
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C3665472
- UMLS CUI [2]
- C0279025
- UMLS CUI [3]
- C0021083
- UMLS CUI [4]
- C0020402
Descripción
prior radiation therapy with volume of bone marrow treated over 25%.
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C1522449
- UMLS CUI [1,2]
- C0005953
- UMLS CUI [1,3]
- C0439165
Descripción
use of immunosuppressive therapy, including systemic steroids within 7 days before the first dose of sg2000.
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0455630
- UMLS CUI [2]
- C0149783
Descripción
hyperleukocytosis (blast counts >30 000/mm3).
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C3805210
Descripción
history of allogeneic stem cell or solid organ transplantation.
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0029216
- UMLS CUI [2]
- C2242529
Descripción
positive serology for human immunodeficiency virus (hiv), hepatitis b or hepatitis c or have hiv-aids, or active hepatitis b or c.
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0019699
- UMLS CUI [2]
- C0744837
- UMLS CUI [3]
- C0850489
- UMLS CUI [4]
- C0001175
Descripción
history of other invasive malignancy within 3 years except for cervical carcinoma in situ, nonmelanomatous carcinoma of the skin or ductal carcinoma in situ of the breast that has been surgically cured.
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0677898
- UMLS CUI [2]
- C0007099
- UMLS CUI [3,1]
- C0007114
- UMLS CUI [3,2]
- C1518408
Descripción
have any coexisting medical condition that will substantially increase the risk associated with the subject's participation in the study.
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C2348568
- UMLS CUI [1,2]
- C1549479
- UMLS CUI [1,3]
- C0012634
Descripción
have psychiatric disorders or altered mental status precluding understanding of the informed consent process and/or completion of necessary studies.
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C1549479
- UMLS CUI [1,3]
- C0004936
Descripción
have persistent grade 2 or greater toxicities from any cause (except alopecia or peripheral neuropathy).
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C2826262
- UMLS CUI [2]
- C0002170
- UMLS CUI [3]
- C0031117
Descripción
are pregnant or breast-feeding.
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0549206
- UMLS CUI [2]
- C0006147
Similar models
Eligibility Acute Myeloid Leukemia NCT02034227
- StudyEvent: Eligibility Acute Myeloid Leukemia NCT02034227
C0205269 (UMLS CUI [1,2])
C0023467 (UMLS CUI [2,1])
C0035020 (UMLS CUI [2,2])
C0001779 (UMLS CUI [3])
C0278787 (UMLS CUI [4,1])
C0332293 (UMLS CUI [4,2])
C0059985 (UMLS CUI [4,3])
C0023434 (UMLS CUI [5,1])
C0332293 (UMLS CUI [5,2])
C0002073 (UMLS CUI [5,3])
C0879626 (UMLS CUI [1,2])
C0002170 (UMLS CUI [2])
C0442874 (UMLS CUI [3])
C0332298 (UMLS CUI [1,2])
C0020402 (UMLS CUI [1,3])
C0232805 (UMLS CUI [2])
C0430064 (UMLS CUI [2])
C1522449 (UMLS CUI [2])
C0021083 (UMLS CUI [3])
C1531518 (UMLS CUI [4])
C0279025 (UMLS CUI [5])
C0279025 (UMLS CUI [2])
C0021083 (UMLS CUI [3])
C0020402 (UMLS CUI [4])
C0005953 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
C0149783 (UMLS CUI [2])
C2242529 (UMLS CUI [2])
C0744837 (UMLS CUI [2])
C0850489 (UMLS CUI [3])
C0001175 (UMLS CUI [4])
C0007099 (UMLS CUI [2])
C0007114 (UMLS CUI [3,1])
C1518408 (UMLS CUI [3,2])
C1549479 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,3])
C1549479 (UMLS CUI [1,2])
C0004936 (UMLS CUI [1,3])
C0002170 (UMLS CUI [2])
C0031117 (UMLS CUI [3])
C0006147 (UMLS CUI [2])